By examining sequence similarity between the V3-loop of gpl20 from various HIV-1 isolates and human proteins, we found that the V3 loop portion KKGIAIGPGR in strain New York 5 (HIV-1NY5) shares 70% identical residues with the collagen-like region (CLR) (16), in which all overlapping 11 residue V3 loop segments were aligned with the sequences from the 5th release of the Kabat's collection of immunologically interesting proteins (17), revealed homology (i.e., 70% residue identity) between a 10-residues-long V3 loop segment from isolate New York 5 (HIV-1NY5) and the collagen-like region (CLR) of human complement component Clq-A (Fig. la) . Their common motif KKG*A**PGR, denoted patt6b, overlaps the conserved "crown" motif GPGRA located at the tip of the V3 loop (Fig. lb) (Fig. lb) was determined by either RIA or ELISA. The majority of the AIDS sera (10 of 12 tested) do contain antibodies recognizing the V3 loop peptide (Fig. 2A) . However, neither does the unrelated peptide bind antibodies from AIDS sera, nor does the V3 loop peptide recognize antibodies from 9 healthy blood donors' sera ( Fig. 2A) . Next, we asked whether antibodies purified from a particular AIDS serum on the V3 loop peptide-affinity column will bind to Clq molecules. Figure 2B shows 
The concept that idiotopes on immunoglobulin variable region (Ig V) can mimic epitopes on other kinds of molecules ( 1 ) has been successfully applied to the production of antiidiotype antibodies (Ab2ß) that mimic the binding domain of viral cell-attachment proteins (2) . Ab2ß vaccines are now considered a promising route for the induction of antiviral immunity through the involvement of the idiotype network (see ref. 3 for review). A general problem of this approach lies in the fact that viruses very often utilize lymphocyte surface molecules as receptors for infection (4) . The (6) . Despite the polymorphism of HIV-1 gpl20, different isolates bind to the same CD4 molecule, suggesting that conserved rather than unique gpl20 regions are the likely participants in receptor binding. Antibodies to the CD4 binding site of HIV block CD4 binding (7) . These antibodies are group-specific but do not appear to effectively neutralize viral infectivity, suggesting that the primary neutralization epitope(s) and the CD4 binding epitope on gpl20 may be separate. The major and highly type-specific neutralizing epitope on gpl20 appears to be the so-called V3 loop, which extensively varies in amino acid sequence among different isolates (8, 9) . The V3-specific neutralizing antibodies occur early in acute infection and prevent the penetration of the virus into the cell. Even though the variability of the V3 loop seems to be the major mechanism for the production of escape mutants (10) , the V3 loop is widely considered as one of the main candidates for vaccine design. The molecular basis of this approach is a short consensus motif within the V3 loop (the "crown" motif) shared by HIV-1 isolates from both Europe and the United States (11) .
According to our previous results, a gpl20 region of about 45 residues, encompassing the V3 loop and 10 residues upstream, shares several features with immunoglobulin heavy chain variable regions (Ig VH). The common features include (i) similarity of consensus sequences (12, 13) , (ii) similar distribution of residue variability (13) , and (iii) similarity of secondary structure propensity profiles (14) . Therefore we have proposed that idiotope structures present on Ig V domains also might be present on gpl20 (15) . Since the antiidiotype approach is considered as an important vaccine strategy for HIV (3) , it would be of interest to investigate possible similarities between the major neutralizing epitope on gpl20 and human proteins, especially those of immunological interest.
In the present study we report local homology detected between a particular V3 loop and several human proteins. The analysis of 23 different V3 loops found in Swiss-Prot 25 (16) , in which all overlapping 11 residue V3 loop segments were aligned with the sequences from the 5th release of the Kabat's collection of immunologically interesting proteins (17), revealed homology (i.e., 70% residue identity) between a 10-residues-long V3 loop segment from isolate New York 5 (HIV-1NY5) and the collagen-like region (CLR) of human complement component Clq-A (Fig. la) . Their common motif KKG*A**PGR, denoted patt6b, overlaps the conserved "crown" motif GPGRA located at the tip of the V3 loop (Fig. lb) (Fig. lb) was determined by either RIA or ELISA. The majority of the AIDS sera (10 of 12 tested) do contain antibodies recognizing the V3 loop peptide (Fig. 2A) . However, neither does the unrelated peptide bind antibodies from AIDS sera, nor does the V3 loop peptide recognize antibodies from 9 healthy blood donors' sera ( Fig. 2A) . Next, we asked whether antibodies purified from a particular AIDS serum on the V3 loop peptide-affinity column will bind to Clq molecules. Figure 2B shows that affinity-purified antibodies react (16) , was compared as a whole and in 11-mer fragments with the proteins from the Kabat 5 database (17) using Fastdb (18, 19) and Chopper (20) . (a) Alignment of the V3 loop from HIV-1NY5 with the collagen-like region (CLR) of human complement component Clq-A. Their common pattern pattöb is present uniquely in these two sequences, as established by pattern-matching searches performed by Quest (19) against databases Swiss-Prot 25, Kabat 
